A18.1
Tuberculosis of genitourinary system
Clinical Classification Guidelines
Medical Intelligence & Overview
Tuberculosis of the genitourinary system, classified under ICD-10 code A18.1, is an infectious disease caused by the bacteria Mycobacterium tuberculosis. It primarily affects the kidneys, urinary tract, and reproductive organs. This condition can develop when tuberculosis bacteria spread from the lungs or other parts of the body via the bloodstream or lymphatic system. While more common in developing countries, it can occur anywhere and requires appropriate medical evaluation and management.
Causes & Symptoms
Clinical Causes: Spread of Mycobacterium tuberculosis from pulmonary or other tuberculosis sites through the bloodstream Reinfection or reactivation of a latent infection within the genitourinary organs Inhalation of airborne tuberculosis bacteria leading to systemic dissemination Close contact with individuals who have active tuberculosis
Key Symptoms: Pain or discomfort in the lower back, abdomen, or pelvis Blood in the urine (hematuria) Frequent urination or difficulty urinating Unexplained weight loss and fatigue Fever and night sweats Swelling or lumps in the groin area Persistent or recurrent urinary tract infections
Diagnostic & Treatment
Diagnosis Path: Diagnosing genitourinary tuberculosis involves a combination of clinical evaluation, laboratory testing, and imaging studies. Urinalysis may show signs of infection or blood. Urine samples can be examined for bacteria and tested with cultures, polymerase chain reaction (PCR), or acid-fast bacilli (AFB) staining. Imaging tests like ultrasound, CT scans, or MRI may reveal structural differences or lesions in the kidneys or reproductive organs. A biopsy may be necessary in some cases to confirm the diagnosis.
Treatment Protocols: Treatment typically involves a lengthy course of multiple antibiotics specifically targeted at tuberculosis bacteria. The standard regimen often includes drugs such as isoniazid, rifampicin, ethambutol, and pyrazinamide. Adherence to the prescribed treatment plan is crucial to prevent drug resistance and ensure complete eradication of the infection. In some cases, surgical intervention may be necessary to remove damaged tissue or manage complications. Regular follow-up with healthcare providers is essential to monitor progress and address any side effects or issues.
Clinical Advice & FAQs
Billing Guidance
Is A18.1 a billable ICD-10 code?
Yes, A18.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A18.1?
Clinical documentation must specify the nature of Tuberculosis of genitourinary system and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
